2007 Annual meeting of the National Lung Cancer Partnership: A summary of meeting highlights

Journal of Thoracic Oncology

Volumn 3, Issue 2, 2008, Pages 190-193

  Vidaver, Regina M ^a   Schachter, Beth S ^b  

^a National Lung Cancer Partnership   (United States)

^b Still Point Coaching and Consulting   (United States)

Author keywords

Bronchioloalveolar; DNA methylation; Drug resistance; EGFR; Epigenetic; KRAS

Indexed keywords

2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; ERLOTINIB; GEFITINIB; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N (2,3 DIHYDROXYPROPOXY) 3,4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO)BENZAMIDE; PACLITAXEL;

CANCER DIAGNOSIS; CANCER PATIENT; CONFERENCE PAPER; DNA METHYLATION; DRUG TOLERANCE; EPIDERMAL GROWTH FACTOR RECEPTOR GENE; EPIGENETICS; ESTROGEN RESPONSIVE ELEMENT; GENE; GENE AMPLIFICATION; GENE MUTATION; GENE SILENCING; GENETICS; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; MESENCHYMAL EPITHELIAL TRANSITION FACTOR GENE; ONCOGENE K RAS; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 40049086528     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181622c43     Document Type: Conference Paper

References (6)

1. Catalog of Somatic Mutations in Cancer Wellcome Trust www.sanger.ac.uk/genetics/CGP/cosmic/
2. HM McDaid L Lopez-Barcons A Grossman Enhancement of the therapeutic efficacy of taxol by the mitogen-activated protein kinase kinase inhibitor CI-1040 in nude mice bearing human heterotransplants Cancer Res 65 2005 2854 2860
3. S Zimmermann K Moelling Phosphorylation and regulation of Raf by Akt (protein kinase B) Science 286 1999 1741 1744
4. WD Travis K Garg WA Franklin Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria J Thorac Oncol 1 9 Suppl 2006 S13 S19
5. JA Engelman K Zejnullahu T Mitsudomi MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling Science 316 2007 1039 1043
6. RM Brena C Morrison S Liyanarachchi Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer PLoS Med 4 2007 e108